139 related articles for article (PubMed ID: 10614724)
1. The concept of specific immune treatment against autoimmune diseases.
Sela M
Int Rev Immunol; 1999; 18(3):201-16. PubMed ID: 10614724
[TBL] [Abstract][Full Text] [Related]
2. Specific vaccines against autoimmune diseases.
Sela M
C R Acad Sci III; 1999 Nov; 322(11):933-8. PubMed ID: 10646086
[TBL] [Abstract][Full Text] [Related]
3. Copolymer 1: from basic research to clinical application.
Teitelbaum D; Arnon R; Sela M
Cell Mol Life Sci; 1997 Jan; 53(1):24-8. PubMed ID: 9117994
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory vaccines against autoimmune diseases.
Sela M
Rejuvenation Res; 2006; 9(1):126-33. PubMed ID: 16608409
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic vaccines in autoimmunity.
Sela M; Mozes E
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14586-92. PubMed ID: 15308777
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1.
Teitelbaum D; Arnon R; Sela M
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3842-7. PubMed ID: 10097125
[TBL] [Abstract][Full Text] [Related]
7. A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses.
Katz-Levy Y; Paas-Rozner M; Kirshner S; Dayan M; Zisman E; Fridkin M; Wirguin I; Sela M; Mozes E
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3200-5. PubMed ID: 9096370
[TBL] [Abstract][Full Text] [Related]
8. Cop 1 as a candidate drug for multiple sclerosis.
Teitelbaum D; Arnon R; Sela M
J Neural Transm Suppl; 1997; 49():85-91. PubMed ID: 9266417
[TBL] [Abstract][Full Text] [Related]
9. New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis.
Arnon R; Sela M; Teitelbaum D
J Neurol; 1996 Apr; 243(4 Suppl 1):S8-13. PubMed ID: 8965119
[TBL] [Abstract][Full Text] [Related]
10. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1.
Aharoni R; Teitelbaum D; Sela M; Arnon R
J Neuroimmunol; 1998 Nov; 91(1-2):135-46. PubMed ID: 9846830
[TBL] [Abstract][Full Text] [Related]
11. Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses.
Teitelbaum D; Fridkis-Hareli M; Arnon R; Sela M
J Neuroimmunol; 1996 Feb; 64(2):209-17. PubMed ID: 8632064
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy.
Teitelbaum D; Brenner T; Abramsky O; Aharoni R; Sela M; Arnon R
Mult Scler; 2003 Dec; 9(6):592-9. PubMed ID: 14664472
[TBL] [Abstract][Full Text] [Related]
13. Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes.
Faber-Elmann A; Paas-Rozner M; Sela M; Mozes E
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14320-5. PubMed ID: 9826698
[TBL] [Abstract][Full Text] [Related]
14. Glatiramer acetate.
Comi G; Moiola L
Neurologia; 2002 May; 17(5):244-58. PubMed ID: 12031214
[TBL] [Abstract][Full Text] [Related]
15. Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis.
Zisman E; Katz-Levy Y; Dayan M; Kirshner SL; Paas-Rozner M; Karni A; Abramsky O; Brautbar C; Fridkin M; Sela M; Mozes E
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4492-7. PubMed ID: 8633096
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs.
Katz-Levy Y; Kirshner SL; Sela M; Mozes E
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7000-4. PubMed ID: 7688469
[TBL] [Abstract][Full Text] [Related]
17. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Kleist C; Mohr E; Gaikwad S; Dittmar L; Kuerten S; Platten M; Mier W; Schmitt M; Opelz G; Terness P
J Transl Med; 2016 May; 14(1):99. PubMed ID: 27131971
[TBL] [Abstract][Full Text] [Related]
18. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis.
Aharoni R; Teitelbaum D; Sela M; Arnon R
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10821-6. PubMed ID: 9380718
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice.
Paas-Rozner M; Dayan M; Paas Y; Changeux JP; Wirguin I; Sela M; Mozes E
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2168-73. PubMed ID: 10681457
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis.
Dayan M; Sthoeger Z; Neiman A; Abarbanel J; Sela M; Mozes E
Hum Immunol; 2004 Jun; 65(6):571-7. PubMed ID: 15219376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
